Overview

Biopharma Informatic is a dedicated research site in Houston, Texas. As an organization, we've been conducting clinical trials since 2010 and have since established our own suite here in the medical professional building. Our team is dedicated to the excellence of executing clinical trials both administratively and clinically as we advance medicine through clinical research.

Research Experience

This research site is made up of 10 excellent physicians specializing in: Cardiovascular Medicine, Endocrinology, Gastroenterology, Internal Medicine, Nephrology, Neurology, Ophthalmology, Pain Management, Podiatry, Rheumatology and Women's Health.

Sponsors we've collaborated with:

In the decade+ of our research experience we have primarily serviced phase II, III & IV outpatient clinical trials in the following primary indications including, but not limited to:

Facility Description

Biopharma Informatic is an outpatient facility equipped with an echocardiographic machine, treadmill, EKG, height/weight scale, multiple locked freezers (-20 and -70), locked refrigerator, locked ambient cabinet, on-site lab with centrifuge, min/max TMDs and a large temperature-controlled storage room.

Investigator Experience

• Donald Franklin Gardner, MD — Endocrinology
• Syed Humayun Naqvi, MD — Cardiovascular Medicine
• Rehan Ahmed, MD — Ophthalmology
• Maher Bishara, MD — Nephrology
• Kenrick J. Dennis, DPM — Podiatry
• Joanne Yang-Sun Kim, MD — Neurology
• Agadadash Kuliev, MD — Internal Medicine
• James C. Lai, MD — Pain Management
• Abigail Rebecca Neiman, MD — Rheumatology
• Alexandra Pellicena, MD — OB/GYN
  

Staff Expertise

• John La, Lead CRC
• Cindy Ortega, Senior CRC
• Zeinabou Cissokho, Senior CRC
• Stephanie Alva, CRC
• Insia Naqvi, CRC
• Amal Shaikh, Regulatory Manager
• Kara Canjura, Finance Manager
• Lesley Lancaster, Business Development Associate
• Lucy Jones, Project Manager — Recruitment
• Cortney Lenz, Director of Operations
• Shuja Naqvi, CEO
  

Other information

• Central IRB; and
• Rapid turnaround times for Regulatory completion, IRB submission and Budget/CTA Execution.